New Delhi : Diagnostic chain Dr Lal PathLabs raised over Rs 191 crore from anchor investors by selling shares at a price of Rs 550 apiece. The company’s initial public offer aims to raise up to Rs 638 crore.
Price band for the offer has been fixed at Rs 540-550 per share and the allotment to anchor investors has been done at the higher end.
At the price of Rs 550 apiece, the company would mop up Rs 191.40 crore from the anchor investors, including Reliance Life Insurance and Birla SunLife.
Mumbai–Pune Expressway: Fresh Traffic Jam at Bhor Ghat After Massive 32-Hour Gridlock
Propylene Gas Leak Made Mumbai-Pune Expressway Tanker Operation Highly Hazardous: Expert
Repo Rate Stays At 5.25% After RBI MPC Meet, Yet Smart Borrowers May Still Unlock Big Home Loan EMI Savings
Sri Lanka Cricket Appeals To Pakistan Amid ICC T20 World Cup Boycott Controversy, Citing '2009 Lahore Attack'
